Zobrazeno 1 - 10
of 48
pro vyhledávání: '"R E Schopf"'
Publikováno v:
Monatsschrift Kinderheilkunde. 165:325-332
Solitare Hamangiome im Kindesalter konnen bei ungunstiger Lokalisation oder rascher Wachstumstendenz ein Problem darstellen, auch wenn es sich per se um eine gutartige Gefasproliferation handelt. Da es im Einzelfall nicht vorhersehbar ist, ob sich ei
Autor:
Carle Paul, R. E. Schopf, Akimichi Morita, Diamant Thaçi, Bardur Sigurgeirsson, Phoebe Rich, Charis Papavassilis, J.-P. Ortonne, K. Roseau, Matthias Machacek, Achim Guettner, Evita Harfst
Publikováno v:
British Journal of Dermatology. 168:402-411
Background: Interleukin-17A has major proinflammatory activity in psoriatic lesional skin. Objectives: Assess the efficacy and safety of secukinumab, a fully human IgG1κ monoclonal anti-interleukin-17A antibody, in moderate-to-severe plaque psoriasi
Publikováno v:
Andrologia. 20:521-525
The concentration of josamycin was determined in the split ejaculate of 5 volunteers after oral administration for several days. One aim of this investigation was to examine the penetration of the macrolide antibiotic into the prostate and the semina
Autor:
R. E. Schopf, M. Angsten
Publikováno v:
Aktuelle Dermatologie. 33:310-316
Autor:
F. Schilling, R. E. Schopf
Publikováno v:
Aktuelle Rheumatologie. 24:174-179
Publikováno v:
Mycoses. 42:415-420
In this double-blind clinical trial 429 patients (217 terbinafine and 212 clotrimazole) were randomized to receive twice daily terbinafine 1% topical solution for 1 week followed by a vehicle application for 3 weeks, or 1% clotrimazole solution for 4
Publikováno v:
Archives of Dermatological Research. 290:501-507
Mast cells play an important role in the pathological development of many inflammatory and allergic diseases and inhibition of mast cell activation is a potential target for therapeutic intervention. Therefore, the effect of the novel ascomycin macro
Autor:
P, Rich, B, Sigurgeirsson, D, Thaci, J-P, Ortonne, C, Paul, R E, Schopf, A, Morita, K, Roseau, E, Harfst, A, Guettner, M, Machacek, C, Papavassilis
Publikováno v:
The British journal of dermatology. 168(2)
Interleukin (IL)-17A has major proinflammatory activity in psoriatic lesional skin.To assess the efficacy and safety of secukinumab, a fully human IgG1κ monoclonal anti-IL-17A antibody, in moderate-to-severe plaque psoriasis in a phase II regimen-fi
Autor:
M Bräutigam, P. Mischer, H. J. Schulze, Gottfried Weidinger, Gustav Mahrle, E. G. Jung, R. E. Schopf, L. Färber
Publikováno v:
British Journal of Dermatology. 135:752-757
Fifty-five patients with psoriatic arthritis were treated with a low dose of cyclosporin A (CyA) (mean dose 2.7 mg/kg per day) for a period of 6 months to investigate the efficacy of CyA on disease parameters. Significant improvement in the joint com
Publikováno v:
British Journal of Dermatology. 134:18-21
Summary One–hundred and ninety–five patients with toenail tinea unguium were recruited to a multicentre double–blind clinical trial. Patients were given 250mg terbinafine or 200 mg itraconazole daily for 12 weeks, with follow–up for a further